Salvinorin B methoxymethyl ether, also known as 2-O-methoxymethylsalvinorin B (2-MMSB) is a semisynthetic analogue of the natural product salvinorin A which is used in scientific research. It has a longer duration of action of around 2 to 3 hours, compared to less than 30 minutes for salvinorin A, and has increased affinity and potency at the κ-opioid receptor. It is prepared from salvinorin B. The crystal structure is almost superimposable with that of salvinorin A. Structures bound to the κ-opioid receptor have also been reported. Salvinorin B methoxymethyl ether has a Ki of 0.60 nM at the κ opioid receptor, and is around five times more potent than salvinorin A in animal studies, although it is still only half as potent as its ethoxymethyl ether homologue, salvinorin B ethoxymethyl ether (2-O-ethoxymethylsalvinorin B; 2-EMSB; "symmetry"). The drug was encountered online as a novel designer drug in 2020.
See also κ-Opioid receptor agonist Salvinorin B 2-O-Ethoxymethylsalvinorin B (2-EMSB) RB-64 (22-thiocyanatosalvinorin A)
References
External links Methoxymethyl salvinorin B - Isomer Design The Three Day Salvia Trip...? - Alien Insect on Drugs (Andrew Gallimore) - Substack


